ALRT

ALR Technologies Inc. [ALRT] Stock Forecast

Q: What is ALR Technologies Inc. stock symbol ?

ALR Technologies Inc. is a US stock, located in Richmond of Va and trading under the symbol ALRT

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

ALRT Stock Summary

EPS has been increasing for the past 3 quarters (Quarter statements)

Earnings are expected to fall -100% next year

Profit margins (-2274.32%) are lower than the previous year (-1593.02%)

ALRT has less than 1 year of cash runway

In the News

ALRT Financial details

Company Rating

Sell

Market Cap

Income

-13.13M

Revenue

9.49K

Book val./share

-0.05

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

14 Aug 2013

P/E

-3.56

Forward P/E

PEG

-0.96

P/S

P/B

-0.62

P/C

P/FCF

Quick Ratio

Current Ratio

Debt / Equity

-0.79

LT Debt / Equity

EPS (TTM)

-0.02

EPS next Y

EPS next Q

EPS this Y

26.14%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

-6.04%

EPS Q/Q

-52.63%

SMA20

SMA50

SMA100

Inst Own

0.04%

Inst Trans

ROA

-4776%

ROE

18%

ROC

Gross Margin

49%

Oper. Margin

-3683%

Profit Margin

-227432%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.025-0.28

52W High

52W Low

RSI

Rel Volume

1.84

Avg Volume

52.11K

Volume

95.78K

Perf Week

-53.05%

Perf Month

Perf Quarter

Perf Half Y

Beta

0.371418

Volatility

0.01%, 0.01%

Prev Close

-37.11%

Price

0.03

Change

-39.39%

ALRT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	-0.01	-0.02	-0.04	-0.02	-0.02
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	-0.11	-0.12	-0.12	-0.06	-0.05
Tangible book value per share	-0.11	-0.12	-0.12	-0.06	-0.05
Share holders equity per share	-0.11	-0.12	-0.12	-0.06	-0.05
Interest debt per share	0.09	0.1	0.12	0.06	0.04
Market cap	13.96M	13.96M	14.76M	19.38M	30.76M
Enterprise value	34.59M	36.5M	39.35M	36.51M	49.91M
P/E ratio	-4.91	-3.39	-1.64	-3.28	-2.59
Price to sales ratio	0	0	0	0	4.12K
POCF ratio	-18.14	-22.31	-20.09	-20.01	-17.4
PFCF ratio	-18.14	-22.31	-20.09	-20.01	-17.4
P/B Ratio	-0.54	-0.49	-0.47	-0.89	-1.27
PTB ratio	-0.54	-0.49	-0.47	-0.89	-1.27
EV to sales	0	0	0	0	6.68K
Enterprise value over EBITDA	-35.29	-16.72	-10.51	-9.61	-7.8
EV to operating cash flow	-44.95	-58.34	-53.57	-37.7	-28.23
EV to free cash flow	-44.95	-58.34	-53.57	-37.7	-28.23
Earnings yield	-0.2	-0.3	-0.61	-0.31	-0.39
Free cash flow yield	-0.06	-0.04	-0.05	-0.05	-0.06
Debt to equity	-0.79	-0.79	-0.79	-0.79	-0.79
Debt to assets	6.63K	6.67K	13.38K	133.49	99.7
Net debt to EBITDA	-21.05	-10.33	-6.57	-4.51	-2.99
Current ratio	0	0	0	0.01	0.01
Interest coverage	-0.57	-1.13	-0.71	-1.81	-1.44
Income quality	0.27	0.15	0.08	0.16	0.21
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	763.93
Research and developement to revenue	0	0	0	0	66.82
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	589.61
Graham number	0.17	0.21	0.31	0.16	0.15
ROIC	0.2	0.37	0.58	0.84	0.82
Return on tangible assets	-913.54	-1.22K	-4.9K	-45.91	-61.57
Graham Net	-0.11	-0.12	-0.12	-0.06	-0.05
Working capital	-25.98M	-28.39M	-31.09M	-21.76M	-24.31M
Tangible asset value	-25.98M	-28.39M	-31.09M	-21.76M	-24.31M
Net current asset value	-25.98M	-28.39M	-31.09M	-21.76M	-24.31M
Invested capital	-0.79	-0.79	-0.79	-0.79	-0.79
Average receivables	0	0	0	0	0
Average payables	471.48K	507.13K	1.07M	1.12M	959.89K
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	116.61K
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.11	0.15	0.29	0.27	0.49
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric	2021-06-30	2021-09-30	2021-12-31	2022-03-31	2022-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	0	0	-0.01	-0.01	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	-0.04	-0.04	-0.04	-0.05	-0.05
Tangible book value per share	-0.04	-0.04	-0.04	-0.05	-0.05
Share holders equity per share	-0.04	-0.04	-0.04	-0.05	-0.05
Interest debt per share	0.04	0.03	0.03	0.04	0.04
Market cap	30.63M	31.21M	31.21M	31.75M	22.37M
Enterprise value	48.12M	49.51M	50.35M	51.64M	42.99M
P/E ratio	-3.3	-4.9	-1.13	-2.55	-3.76
Price to sales ratio	0	14.78K	5.83K	30.44K	22.82K
POCF ratio	-56.88	-70.09	-67.03	-89.75	-63.29
PFCF ratio	-56.88	-70.09	-67.03	-89.75	-63.29
P/B Ratio	-1.38	-1.34	-1.28	-1.25	-0.85
PTB ratio	-1.38	-1.34	-1.28	-1.25	-0.85
EV to sales	0	23.44K	9.4K	49.51K	43.87K
Enterprise value over EBITDA	-93.24	-46.09	-11.79	-60.45	-46.3
EV to operating cash flow	-89.37	-111.19	-108.15	-145.96	-121.67
EV to free cash flow	-89.37	-111.19	-108.15	-145.96	-121.67
Earnings yield	-0.08	-0.05	-0.22	-0.1	-0.07
Free cash flow yield	-0.02	-0.01	-0.01	-0.01	-0.02
Debt to equity	-0.8	-0.79	-0.79	-0.79	-0.79
Debt to assets	41.16	172.15	99.7	75.05	214.24
Net debt to EBITDA	-33.9	-17.04	-4.48	-23.28	-22.21
Current ratio	0.02	0	0.01	0.01	0
Interest coverage	-0.27	-2.07	1.12	1.55	-1.66
Income quality	0.23	0.28	0.13	0.25	0.24
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	448.11	742.85	696.49	824.11
Research and developement to revenue	0	60.82	24.34	122.93	124.03
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	257.77	453.67	306.6	202.93
Graham number	0.06	0.05	0.11	0.08	0.05
ROIC	0.11	0.22	0.33	-0.36	0.17
Return on tangible assets	-5.34	-14.97	-35.88	-11.65	-15.44
Graham Net	-0.04	-0.04	-0.04	-0.05	-0.05
Working capital	-22.22M	-23.24M	-24.31M	-25.37M	-26.26M
Tangible asset value	-22.22M	-23.24M	-24.31M	-25.37M	-26.26M
Net current asset value	-22.22M	-23.24M	-24.31M	-25.37M	-26.26M
Invested capital	-0.8	-0.79	-0.79	-0.79	-0.79
Average receivables	0	0	0	12.5	12.5
Average payables	1.1M	812.58K	746.97K	899.56K	1.03M
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	2.16	0
Days payables outstanding	0	45.69K	62.11K	150.46K	217.87K
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	41.72	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.1	0.07	0.29	0.12	0.06
Capex per share	0	0	0	0	0

ALRT Frequently Asked Questions

What is ALR Technologies Inc. stock symbol ?

ALR Technologies Inc. is a US stock , located in Richmond of Va and trading under the symbol ALRT

What is ALR Technologies Inc. stock quote today ?

ALR Technologies Inc. stock price is $0.03 today.

Is ALR Technologies Inc. stock public?

Yes, ALR Technologies Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 52.11K
Employee 6
CEO Mr. Sidney S. Chan
Headquarters Richmond,VA,US
IPO Date 2000-03-14
Website https://www.alrt.com

ALR Technologies Inc., a data management company, develops diabetes care solutions for human and animal health in the United States. It provides Diabetes Management System, a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring, and diabetes test supplies. The company also offers Continuous Glucose Monitoring (CGM), a medical device that is worn on the body of a diabetic subject for blood sugar readings; and GluCurve Pet CGM to address an unmet need in diabetes care for felines and canines used by veterinarians in animal health, as well as Prediabetes System, which provides patients with educational videos and supplemental content formatted for mobile devices and a private online community to discuss disease management. Its primary business markets are health care providers, the providers of health insurance, and the providers of disease and case management services, including the home care industry. The company was formerly known as Mo Betta Corp. and changed its name to ALR Technologies Inc. in December 1998. ALR Technologies Inc. was incorporated in 1987 and is based in Richmond, Virginia.